The China Post
Date: March 8, 2017
By: Sun Hsin Hsuan
The Food and Drug Administration (FDA) ordered a recall Tuesday of Taiwan’s most
widely used lipid-lowering drug after more counterfeit versions of the drug were found.
The drug’s maker, pharmaceutical giant AstraZeneca, issued a statement through its Taiwan affiliate on Tuesday announcing a recall of the Crestor (冠脂妥) drug in a joint effort with the FDA.
FDA Director Wu Shou-mei (吳秀梅) said investigators had found counterfeit Crestor drugs with the batch number MK479.
The discovery came after counterfeit Crestor drugs with the batch number MV503 were found on Sunday.
“Given that the FDA has been unable to confirm how many batches of fake Crestor drugs have entered the market, the administration and AstraZeneca Taiwan have decided to recall all Crestor drugs currently used or sold at hospitals and pharmacies nationwide,” Wu said. [FULL STORY]